Related Content
Search Google Scholar for:
|
|
Science 24 August 1990: Vol. 249. no. 4971, pp. 875 - 884 DOI: 10.1126/science.2203142
|
|
Articles
Science, Vol 249, Issue 4971, 875-884
Copyright © 1990 by American Association for the Advancement of Science
Bovine growth hormone: human food safety evaluation
JC Juskevich
and
CG Guyer
Food and Drug Administration, Center for Veterinary Medicine, Office of New Animal Drug Evaluation, Rockville, MD 20857.
Scientists in the Food and Drug Administration (FDA), after reviewing the scientific literature and evaluating studies conducted by pharmaceutical companies, have concluded that the use of recombinant bovine growth hormone (rbGH) in dairy cattle presents no increased health risk to consumers. Bovine GH is not biologically active in humans, and oral toxicity studies have demonstrated that rbGH is not orally active in rats, a species responsive to parenterally administered bGH. Recombinant bGH treatment produces an increase in the concentration of insulin-like growth factor-I (IGF-I) in cow's milk. However, oral toxicity studies have shown that bovine IGF-I lacks oral activity in rats. Additionally, the concentration of IGF-I in milk of rbGH-treated cows is within the normal physiological range found in human breast milk, and IGF-I is denatured under conditions used to process cow's milk for infant formula. On the basis of estimates of the amount of protein absorbed intact in humans and the concentration of IGF-I in cow's milk during rbGH treatment, biologically significant levels of intact IGF-I would not be absorbed.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Parental characteristics as predictors of birthweight.
- F. Xue, W. C. Willett, B. A. Rosner, M. R. Forman, and K. B. Michels (2008)
Hum. Reprod.
23, 168-177
| Abstract »
| Full Text »
| PDF »
- The Effects of Dairy Processes and Storage on Insulin-Like Growth Factor-I (IGF-I) Content in Milk and in Model IGF-I-Fortified Dairy Products.
- S. H. Kang, J. U. Kim, J. Y. Imm, S. Oh, and S. H. Kim (2006)
J Dairy Sci
89, 402-409
| Abstract »
| Full Text »
| PDF »
- Dairy Product Consumption and the Risk of Breast Cancer.
- P. W. Parodi (2005)
J. Am. Coll. Nutr.
24, 556S-568S
| Abstract »
| Full Text »
| PDF »
- Nutritional Predictors of Insulin-like Growth Factor I and Their Relationships to Cancer in Men.
- E. Giovannucci, M. Pollak, Y. Liu, E. A. Platz, N. Majeed, E. B. Rimm, and W. C. Willett (2003)
Cancer Epidemiol. Biomarkers Prev.
12, 84-89
| Abstract »
| Full Text »
| PDF »
- Dietary Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations.
- M. D. Holmes, M. N. Pollak, W. C. Willett, and S. E. Hankinson (2002)
Cancer Epidemiol. Biomarkers Prev.
11, 852-861
| Abstract »
| Full Text »
| PDF »
- Milk Intake, Circulating Levels of Insulin-Like Growth Factor-I, and Risk of Colorectal Cancer in Men.
- J. Ma, E. Giovannucci, M. Pollak, J. M. Chan, J. M. Gaziano, W. Willett, and M. J. Stampfer (2001)
J Natl Cancer Inst
93, 1330-1336
| Abstract »
| Full Text »
| PDF »
- Re: Role of the Insulin-Like Growth Factors in Cancer Development and Progression.
- S. S. Epstein (2001)
J Natl Cancer Inst
93, 238
| Full Text »
| PDF »
- Biology of Somatotropin in Growth and Lactation of Domestic Animals.
- T. D. ETHERTON and D. E. BAUMAN (1998)
Physiol Rev
78, 745-761
| Abstract »
| Full Text »
| PDF »
- Bovine Somatotropin.
- D. S. Kronfeld (1991)
JAMA
265, 1389
| Abstract »
| PDF »
- Biotechnology and the American Agricultural Industry.
- Council on Scientific Affairs, American Medical As (1991)
JAMA
265, 1429-1436
| Abstract »
| PDF »
- Safety of bovine growth hormone.
- (1991)
Science
251, 256-257
| PDF »
- FDA publishes bovine growth hormone data.
- A Gibbons (1990)
Science
249, 852-853
| PDF »
|
|